ADVM · Adverum Biotechnologies Inc.
Acquired Company
Eli Lilly completed the acquisition of Adverum Biotechnologies on December 9, 2025.
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops candidate gene therapy products to treat eye and rare diseases. The company is headquartered in Redwood City, California.
100 CARDINAL WAY, REDWOOD CITY, CA, UNITED STATES, 94063, Redwood City, CA, 94063, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
96.26M
52 Wk Range
$3.98 - $5.75
Previous Close
$4.36
Open
$4.36
Volume
N/A
Day Range
$4.36 - $4.36
Enterprise Value
159.1M
Cash
26.06M
Avg Qtr Burn
-28.12M
Insider Ownership
13.21%
Institutional Own.
88.31%
Qtr Updated
Sep 30th 2025